'Molecular Targets and Cancer Therapeutics'
The revolution in understanding the molecular basis of cancer has lead to the discovery and development of numerous innovative agents – 'designer' diagnostics, new prognostic tests, 'smart' drugs and other entirely novel ways of tackling cancer.
To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.
Three of the world's leading cancer organisations:
The European Organisation for Research and Treatment of Cancer; The USA's National Cancer Institute; The American Association for Cancer Research;
will join forces in Geneva from 28 September to 1 October to provide a platform for presentation of the latest findings in drug research and development to around 2,000 international experts in the field.
All data at the four-day meeting are being presented for the first time.
We welcome the media to the symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter from the editor of the journal they represent stating that they are being commissioned to write a report for publication.
A media centre with computing, fax, photocopying and free international phone and internet connections will be available.
NB: the official language of the symposium is English and all press materials will be in English.
To register: contact Margaret Willson for a registration form or download one from the conference website.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
In the middle of difficulty lies opportunity.
-- Albert Einstein